Clinical Trials Directory

Trials / Unknown

UnknownNCT00602186

Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Tabriz University · Academic / Other
Sex
Female
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)

Detailed description

Voiding dysfunction is not uncommon in Tabriz.About 20% of patients in female urology clinic of Tabriz university of medical sciences sufered from some degrees of voiding dysfunction (due to bladder imparement or bladder outlet obstruction).There is limited information about medical treatment of those patients. On the other hand alpha adrenergic blockers are the first choice medication in BENIGN PROSTATIC HYPERPLASIA. There is some new facts about destribution of alpha adrenergic blockers in female pelvic floor.The purpose of this study is to comparision whether Tamsolusin 0.4/daily or Prazosin 1 mg/daily are effective in the treatment of female voiding dysfunction(BOO)

Conditions

Interventions

TypeNameDescription
DRUGtamsolusin0.4 mg /day
DRUGprazosin1 mg/day

Timeline

Start date
2005-07-01
Primary completion
2007-03-01
Completion
2008-03-01
First posted
2008-01-28
Last updated
2008-01-29

Source: ClinicalTrials.gov record NCT00602186. Inclusion in this directory is not an endorsement.